Capital Research Global Investors’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$147M Sell
2,190,368
-2,653,939
-55% -$194M 0.02% 269
2026
Q1
$370M Buy
4,844,307
+988,578
+26% +$71.3M 0.06% 192
2025
Q4
$246M Sell
3,855,729
-349,075
-8% -$21.5M 0.05% 203
2025
Q3
$265M Sell
4,204,804
-41,489
-1% -$2.9M 0.05% 195
2025
Q2
$317M Sell
4,246,293
-1,882,104
-31% -$148M 0.06% 173
2025
Q1
$540M Buy
6,128,397
+241,833
+4% +$22.8M 0.12% 136
2024
Q4
$538M Buy
5,886,564
+697,388
+13% +$71.5M 0.11% 138
2024
Q3
$581M Buy
5,189,176
+237,074
+5% +$23.7M 0.12% 132
2024
Q2
$485M Buy
4,952,102
+440,636
+10% +$43.7M 0.11% 146
2024
Q1
$452M Buy
4,511,466
+3,909,740
+650% +$344M 0.1% 155
2023
Q4
$54M Buy
+601,726
New +$48M 0.01% 316

Other funds holding EMN

Capital Research Global Investors's EMN Position: Q2 2026 in Review

Capital Research Global Investors reduced its Eastman Chemical (EMN) stake by 55% in Q2 2026, selling an estimated $194M and leaving 2,190,368 shares worth $147M. The position accounts for 0.02% of the portfolio, ranked #269.

Capital Research Global Investors first reported a position in EMN in Q4 2023 and has held it in 11 quarters since. The position peaked at $581M in Q3 2024. 646 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Capital Research Global Investors held 2,190,368 shares of Eastman Chemical worth $147M as of Q2 2026.
  • Capital Research Global Investors sold 2,653,939 Eastman Chemical shares in Q2 2026, an estimated $194M.
  • Eastman Chemical made up 0.02% of Capital Research Global Investors's portfolio in Q2 2026, its #269 holding.
  • Capital Research Global Investors first reported a position in Eastman Chemical in Q4 2023 and has held it in 11 quarters since.
  • Capital Research Global Investors's Eastman Chemical position peaked at $581M in Q3 2024.
  • 646 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Capital Research Global Investors's 13F filing for Q2 2026, filed 12 Aug 2026.